WLPWM
ARKG icon

Walled Lake Planning & Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Walled Lake Planning & Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9
Closed -$1K – 323
2021
Q2 		$1K Hold
9
– – ﹤0.01% 298
2021
Q1 		$1K Buy
+9
New +$893 ﹤0.01% 293

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Walled Lake Planning & Wealth Management's ARKG Position: Q3 2021 in Review

Walled Lake Planning & Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 9 shares — an estimated $1K sold.

Walled Lake Planning & Wealth Management first reported a position in ARKG in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Walled Lake Planning & Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Walled Lake Planning & Wealth Management sold 9 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $1K.
  • Walled Lake Planning & Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 2 quarters.
  • Walled Lake Planning & Wealth Management's ARK Genomic Revolution ETF position peaked at $1K in Q2 2021.
  • 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Walled Lake Planning & Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.